Trade PDSB stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
PDS Biotechnology Corporation (PDSB) is trading at US$0.59, up 46.65% today as of Sep 15, 16:00 EDT. The company has a market capitalisation of US$12.23M. Over the past 52 weeks, PDSB has traded between US$0.20 and US$1.55. On Syfe you can trade PDSB with $0 commission and add it to your watchlist.
| Previous close | US$0.40 |
|---|---|
| Market cap | US$12.23M |
| 52-week range | US$0.20 – US$1.55 |
| Volume | 360.78M |
| Exchange | US |
Add to Watchlist
Set Price Alert
PDS Biotechnology Corporation
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products include PDS0101 and PDS01ADC. The company was founded by Frank K. Bedu-Addo in 2005 and is headquartered in Princeton, NJ.
Year: 2015
PDS Biotechnology Corporation (PDSB) stock is trading at US$0.59, +46.65% from the previous close of US$0.40.
The market cap for PDS Biotechnology Corporation (PDSB) stock is approximately US$12.23M.
The 52-week high for PDS Biotechnology Corporation (PDSB) stock is US$1.55.
The 52-week low for PDS Biotechnology Corporation (PDSB) stock is US$0.20.
PDS Biotechnology Corporation (PDSB) does not currently pay a dividend.
Stay on top of PDSB
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
